Nanoscope Therapeutics Announces Publication of Preclinical Data Showing Targeted, Durable Vision Restoration with OCT-Guided, Non-Viral Gene Delivery
Optical coherence tomography (OCT)-guided nano-enhanced optical delivery (NOD) delivered multi-characteristic opsin (MCO) genes to precisely selected regions of the retina without a viral vector A single treatment produced retinal and cortical light responses that were sustained for up to...
Covered in this story
Analyst targets on Moody's Corporation
- Jefferies: $484 → $560 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MCO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Moody's Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.